HC
TEVA icon

Hara Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Hara Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.9K Hold
2,800
– – 0.05% 155
2026
Q1 		$84.3K Hold
2,800
– – 0.04% 160
2025
Q4 		$87.4K Sell
2,800
-12,092
-81% -$298K 0.05% 152
2025
Q3 		$301K Sell
14,892
-100
-0.7% -$1.76K 0.18% 98
2025
Q2 		$251K Sell
14,992
-16,822
-53% -$271K 0.16% 113
2025
Q1 		$489K Buy
31,814
+1,434
+5% +$25.6K 0.33% 75
2024
Q4 		$670K Sell
30,380
-2,400
-7% -$43.7K 0.42% 55
2024
Q3 		$591K Sell
32,780
-30
-0.1% -$525 0.37% 60
2024
Q2 		$533K Buy
+32,810
New +$505K 0.34% 70

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Hara Capital's TEVA Position: Q2 2026 in Review

Hara Capital held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 2,800 shares worth $94.9K. The position accounts for 0.05% of the portfolio, ranked #155.

Hara Capital first reported a position in TEVA in Q2 2024 and has held it in 9 quarters since. The position peaked at $670K in Q4 2024. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Hara Capital held 2,800 shares of Teva Pharmaceuticals worth $94.9K as of Q2 2026.
  • Hara Capital left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.05% of Hara Capital's portfolio in Q2 2026, its #155 holding.
  • Hara Capital first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Hara Capital's Teva Pharmaceuticals position peaked at $670K in Q4 2024.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.